Clinical Trials

Open Clinical Trials

HIC 0809004248
Scott Gettinger M.D. 
Sorafenib Long Term Extension Program (STEP)

HIC 0708002987
Scott Gettinger M.D. 
A Phase I/II Trial of Induction Carboplatin/Paclitaxel with Bevacizumab Followed by Concurrent Thoracic Conformal Radiation Therapy with Carboplatin/ Paclitaxel, Bevacizumab and Erlotinib in Stage III A/B Non-small Cell Lung Cancer

HIC 0811004507
Roy Decker M.D., PhD 
A Dose Escalation Study of Vorinostat in Combination with Palliative Radiotherapy for Patients with Non-Small Cell Lung Cancer

HIC 0707002901
Scott Gettinger M.D. 
Phase I/II Trial of Induction Carboplatin/Paclitaxel with Bevacizumab followed by Concurrent Thoracic Conformal Radiation Therapy with Carboplatin/ Paclitaxel, Bevacizumab and Erlotinib in Stage III A/B Non-small Cell Lung Cancer

HIC 0904005074
Scott Gettinger M.D. 
(ECOG 1505) A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (greater than or equal to 4 cm)-IIIA Non-Small Cell Lung Cancer (NSCLC)

HIC 0805003786
Scott Gettinger M.D. 
A Phase 1/2 Study of XL184 with or without Erlotinib in Subjects with Non-Small Cell Lung Cancer